May 20, 2026Journal of the American College of Cardiology
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceKey expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“This update was motivated largely by changes in the management of aortic stenosis related to several important, new studies on transcatheter aortic valve replacement showing better outcomes in lower-risk patients as well as in higher-risk patients. We also looked across the spectrum of valvular heart disease and found other updates were needed as well.”
“This will be the first time the guideline says that it's okay to use the newer oral anticoagulants in valve patients. So we're saying to treat people with valve disease with A-fib just like you treat everybody else with atrial fibrillation unless they have a prosthetic valve or rheumatic disease. That, hopefully, will be less confusing for people in the future, because I think up until now we haven't really said that.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Nishimura et al. (2017) studied this question.